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Platelets are small-sized, anucleated cells with a lifespan of 5-8 days that 
circulate within the blood to maintain vessel integrity and to prevent bleeding 
after injury in mammals. Beyond its classical roles platelets are further 
involved in a variety of physiological and pathological processes, like 
inflammation, immune defensing, cancer metastasis, and etc. Each day 
approximately 15×109 to 40×109 platelets are continuously released into the 
circulation by their progenitors, megakaryocytes (MK). MKs represent only 
0.01% of bone marrow (BM) cells, however are able to release several 
hundred platelets by fragmentation from one MK into the circulation by a 
process termed thrombopoiesis. This process goes along with the formation of 
proplatelets, long cell body extensions, which are shedded off. However, these 
precise molecular underlying mechanisms are still largely unknown and only 
few factors, like shear stress or S1P, have been identified to affect this process. 
In particular, the role of other cell types in this process remains elusive, 
considering close proximity of various immune cells with MKs within the bone 
marrow. Herein, we evaluated platelet production in the presence or absence 
of neutrophils. Our data indicates neutrophils augment platelet counts by 
increasing the reticulated platelet biogenesis. Using multiphoton intravital 
microscopy we observed PMN-MK interactions within the interstitium and 
vasculature niches. Our data shows neutrophils in circulation pool dominate 
proplatelet forming and shedding. In addition, using genetic mice in an in vitro 
co-culture assay, we identified the role of CXCR4/SDF-1 and reactive oxygen 
species (ROS) in thrombopoiesis. To do so, we found that these observed 
mechanisms contribute to the diurnal modulation of platelet counts of the day. 
Taken together, we identified PMN-MK interaction within the bone marrow as 





2.1  Megakaryocyte development 
Megakaryocytes mainly reside in the BM, but could also be found in the 
yolk sac, fetal liver in the early development stage, spleen and lung of adult 
animals (Long et al. 1982; Ogawa, 1993; William B. Slayton, et al. 2012; 
Lefrançais E, et al. 2017). Platelets are primarily released from 
megakaryocytes that locate within the bone marrow. However, a recent study 
demonstrated that MKs reside within the lung vasculature and contribute to 
platelet production (Lefrançais E, et al. 2017). Inside the bone marrow, 
megakaryocytes derive from a MK biased progenitor cell (MPC). MPCs are 
derived from haematopoietic stem cell that maintain their self-renewal or 
differentiation capacities throughout lifetime. Within the BM HSCs are able to 
differentiate into different blood lineages including the common lymphoid 
progenitors (CLPs) and common myeloid progenitors (CMPs). Subsequently 
CMP cells undergo cellular differentiation into the granulocyte/macrophage 
progenitors or the megakaryocyte-erythrocyte progenitors (Carolien M. 
Woolthuis, et al. 2016, Haas S, et al. 2015). At later stages, the 
megakaryocyte-erythrocyte progenitors will further develop into 
megakaryocytes or erythrocytes under the effects of a series of different 
chemokines or cytokines, such as IL-3, IL-6, etc. (Broudy VC, et al. 1995; 
Deutsch VR, et al. 2013; Carolien M. Woolthuis, et al. 2016).  
The MK differentiation (termed as Megakaryopoiesis) is primarily regulated 
by thrombopoietin (TPO) that is capable of binding to its receptor (Mpl) on the 
cell surface of MKs to maintain constant platelet counts within the blood 
(Broudy VC, et al. 1995). TPO is primarily produced in the liver and to some 
extent within the BM and kidney (Sungaran R, et al. 1997; Shinguang Qian, et 
al. 1998). Within the blood TPO plasma level show an inverse relationship with 




conditions, hepatocyte derived thrombopoietin release can be regulated 
through a c-MP-mediated hormone uptake and destruction way (Kenneth 
Kaushansky, 2005). Under inflammatory conditions, macrophages released 
IL-6 was found to stimulate TPO release (Kaser A, et al. 2001). Few years ago, 
it was shown that TPO production is regulated through changes of platelet 
surface sialyation pattern, particular on aged platelets (Renata Grozovsky, et 
al. 2015). Even though TPO dominates the differentiation of MK maturation, 
and TPO- and c-Mpl null mice have a severe thrombocytopenia, these mice 
retain their ability to release proplatelet into bone marrow sinusoids. This 
finding furthermore elucidates that TPO and c-Mpl play an important role 
during megakaryopoiesis but not thrombopoiesis (Choi, et al. 1995; Ito, et al. 
1996; Solar GP, et al. 1998). 
 
 





During megakaryopoiesis, TPO drives the differentiation of platelet biased 
hematopoietic stem cells into megakaryocytic progenitors. During their 
maturation, megakaryocyte undergo a process called endomitosis to yield a 
polyploid state without undergoing cell division. This kind of endomitosis has 
been deemed useful to efficiently accumulate the enourmous amounts of 
proteins and RNAs that are transferred in the forming platelets (Zimmet & 
Ravid, 2000; Machlus & Italiano, 2013). Megakaryopoiesis is regulated by 
transcription factors, like GATA-1, friend of GATA-1 (FOG-1), NF-E2, RUNX1, 
etc. (Crispino, J.D. 2005, Avanzi MP, et al. 2014). From these transcription 
factors, GATA-1 plays the prominent role as it facilitates the recruitment of 
chromatin activation and repression elements and other transcription factors, 
like FOG-1, etc. (Crispino, J.D., 2005). Along this line, GATA-1 deficient mice 
exhibit a hyperproliferative and thrombocytopenic phenotype underscoring its 
central role in the megakaryopoiesis (Vyas P, et al. 1999). NF-E2 has also 
been demonstrated that it could drive the differentiation of MKs and impact on 
platelet formation through binding to the Maf recognition element and further 
regulating the maturation stage-specific genes, (Shivdasani RA, et al. 1995; 
Shavit JA, et al. 1998). 
In addition, some stromal cells, like arteriolar cells in the bones, are also 
deemed as determinant to the development of megakaryocytes, as the 
arteriolar niche are associated with the distribution of subsets of quiescent 
HSCs (Kunisaki Y, et al.2013). Initial studies implied that during the maturation 
process MKs translocate from the osteoblastic niche to perivascular niche. 
However, this concept was recently challenged that sinusoid MK precursors 
directly replenished the MK number and their distributions proximately 
associated with the MK niche rather than the arteriolar niche (Stegner D. et al. 





2.2 Leukocyte-platelet interaction 
Beyond their pivotal role in primary hemostasis, platelets have a variety of 
functions during inflammation. Under steady state conditions, platelets 
circulate within the blood in a quiescent state. However, upon activation 
following vascular injury (e.g. atherothrombosis), platelets undergo a shape 
change, secret their granular content and conformationally activate surface 
expressed adhesion molecules (i.e. integrins). The shape change of platelet 
and the expression of adhesive molecules strongly associated with later 
stages of platelet-leukocyte and platelet–endothelium interactions that are 
important for the maintenance of vessel wall integrity and host immune 
defense.  
Platelets communication with leukocytes, mainly neutrophils, by secreting 
proteins and non-protein molecules, for instance ADP, to intercommunicate 
with leukocytes. Moreover, leukocytes are able to release factors, including 
proteases and nitric oxide, to modulate the response of platelets. It has been 
well-known that the platelet-neutrophil interaction is of essential importance 
under various pathophysiological conditions, including bacterial infections, 
sepsis, sickle cell disease, acute lung injury, nocturnal asthma, etc. (Gawaz et 
al. 1995, Pamuk et al. 2006, Polanowska-Grabowska et al. 2010, Gresele et al. 
1993; Caudrillier et al. 2012.). Platelet-neutrophil interactions are mediated 
through several mechanisms: I) platelets express p-selectin (CD62P) binds to 
neutrophil expressed P-selectin glycoprotein ligand-1 (Hamburger and McEver 
1990; Moore et al. 1995), and II) platelet glycoprotein Ibα binds to MAC-1 on 
neutrophils (Simon et al. 2000). Under inflammatory conditions, platelets 
facilitate the adhesion of neutrophils to the activated or injured endothelium 
cells to promote neutrophil transmigration (Sreeramkumar V, et al. 2014; 
Gabriele Zuchtriegel, et al. 2016). Neutrophils act as the first responding cell 




defense. Furthermore, the contribute to variety of cardiovascular diseases (i.e. 
myocardial infarction). Neutrophils use a large armory kill pathogens including 
reactive oxygen species (ROS) and Netosis (Branzk N, et al. 2014). The latter 
one requires the interaction of neutrophil beta2 integrin with the GPIb alpha/ 
αIIbβ3 on platelets or p-selectin/PSGL-1 complex, respectively (Jenne et al. 
2013; Etulain et al. 2015; Caudrillier et al. 2012; Carestia et al. 2016). 
Intravascular netosis triggers microthrombi formation to seal sites of 
inflammation and to prevent dissemination of pathogens. This mechanism 
contributes to a variety of pathological conditions such as thrombosis 
(Martinod and Wagner 2014; Gould et al. 2015), ischemia/reperfusion injury 
(Nakazawa et al. 2017; Sayah et al. 2015; Ge et al. 2017; Huang et al. 2013) 




Fig.2.2 Modes of platelet-neutrophil interactions and its consequences 
(Ton Lisman. 2017). 
 
2.3 Leukocyte-megakaryocyte interaction 
In 1956, Humble, et al. described a biological heterozygous “cell-in-cell” 
phenomenon, termed as “emperipolesis”. Emperipolesis (derived from the 




Humble et al. 1956) describes the active penetration of one cell by another. 
The first observation associated with human megakaryocytic emperipolesis 
was reported by Larsen (Larsen, et al.1970). In comparison to normal cellular 
engulfment phenomenons, the engulfed cells in the emperipolesis remain 
intact and viable. Emperipolesis was described in different physiological and 
pathological conditions (Cashell and Buss, 1992; Mangi and Mufti, 1992; 
Schmitt et al. 2002). Furthermore, Overholtzer et al. reported recently a 
homozygous “cell-in-cell” phenomenon, named as “entosis”, bears many 
similarities with emperipolesis (Overholtzer, et al. 2007).  
Thereby, megakaryocytes engulf neutrophils, monocytes or lymphocytes, 
etc. Emperipolesis mainly appears in different pathological settings. For 
example, emperipolesis could be found under conditions of thrombocytopenia 
(Avci Z, et al. 2002), Hodgkin’s lymphoma (Knight Tristan, et al. 2018), acute 
and chronic leukemia (Shamoto M. 1981), multiple myeloma, and 
myelofibrosis (Schmitt et al. 2002; Spangrude et al. 2016), blood loss (Cashell 
and Buss, 1992) and Rosai-Dorfman disease (Cangelosi JJ, et al. 2011). 
Rosai-Dorfman disease is a rare disorder accompanying with histiocytes 
hyperproliferation in the lymph nodes, most often in cervical lymph nodes. The 
viability in extent of emperipolesis is associated with the activity of 
Rosai-Dorfman disease (Venkateswaran KIyer, et al. 2009) and hence is 
considered as a clinical hallmarker for diagnostics (Varun Rastogi, et al. 2014). 
Furthermore, several in vivo animal studies observed emperipolesis within 
MKs, e.g. after a sublethal irradiation (Bobik R, Dabrowski Z,1995), 
Leishmaniasis model (Claudia Momo, et al. 2014). Worth mentioning, 
emperipolesis could also be found in physiological settings, like the 
megakaryocytic emperipolesis in the fetal liver (Lee WB, et al. 1999). These 
evidences indicate that emperipolesis is a normal but rare and conservative 




As the physiological role of the process remains still elusive, many groups 
investigated the underlying molecular mechanism that drives emperipolesis. 
The study by Overholtzer showed that the formation of the adherence junction 
is the prerequisite of this entosis process (Overholtzer, et al. 2007). 
Furthermore, this process requires a Rho-ROCK signaling pathway mediated 
and myosin-based contractile force change from the recipient cell to allow the 
penetration of the invading cell (Kroemer G, Perfettini JL. 2014). In this setting 
integrins are known to regulate cell plasticity and the internalization of the 
invading cell (Peng Xia, et al. 2008). Previous studies have demonstrated that 
cancer cells expressing epithelial cadherins (E- or P-cadherins) are able to 
remodel the epithelial junctions and to engulf non-transfected parental cells in 
an in vitro growth assay (Overholtzer, et al. 2007). This goes along with the 
activation of the Rho-ROCK signaling that mediates cytoskeletal 







Fig.2.3 Entosis working model (Peng Xia, et al. 2008) 
 
Schmitt et al. reported that TPO-overexpressing megakaryocytes induce 
myelofibrosis within a mouse model. Furthermore, it increases the incidence of 
emperipolesis in the bone marrow (Fig.4). Further investigations revealed that 
this overexpression leads to an augmented fraction of α-granules and further 
overexpresses P-selectin on the cell membrane of the megakaryocytes, 
thereby triggering an intensive cytoskeleton remodeling of megakaryocytes 
(Schmitt A, et al., 2000). 
Although distinct molecular mechanisms that drive megakaryocyte 
emperipolesis have been revealed by different groups, there are still many 
unanswered questions that needs to be clarified, for instance its physiological 
and pathological significances. In comparison to normal phagocytosis that will 
trigger the elimination of the invading by the host cells, emperipolesis will 
preserve cellular integrity and function and resembles a temporarily event only. 
Hence, it could be speculated that this phenomenon may be a protecting 
mechanism for the invading cells to protect them from an otherwise 







Fig.2.4 Electron-microscopic view of a polymorphonuclear (PMN) cell in 
the demarcation membrane system (Schmitt A, et al., 2000).  
  
2.4 Thrombopoiesis and platelet production 
It is widely accepted that TPO predominantly regulates MK proliferation 
and differentiation (Choi et al, 1995; Ito et al, 1996, Solar GP, et al. 1998). 
However, TPO is not involved in later stages of proplatelet forming and 
shedding. Moreover, the exact molecular mechanisms that regulate proplatelet 
generation, shedding and platelet biogenesis are still insufficiently understood.  
During thrombopoiesis, MKs form cellular extensions, called proplatelets, 
that protrude those into the blood flow through the vascular sinusoids. Each 
MK generates thousands of platelets (Kaushansky K.2008). Therefore, MKs 
have to produce enormous amounts of proteins that allow cellular structure 
changes or cytoskeleton rearrangements. (Zhang L. et al., 2014, Satoshi 
Nishimura, et.al, 2015, Kellie R. Machlus, et.l. 2016). Indeed, the most 
abundant structural protein expressed within MKs is beta1-tubulin. Its genetic 
deficiency in mice leads to a 60% decrease of platelets counts. Platelets 




defects. Along this line, patients with a mutation of β1-tubulin develop an 
autosomal dominant inherited macrothrombocytopenia (Freson, K., et al. 
2005).  
  In analogy, the highly expressed F-actin regulates proplatelet formation by 
generating a bifurcation within the proplatelet (Italiano et al., 1999; Patel et al., 
2005). In addition to these structural proteins, contractile elements actively 
contribute to proplatelet formation, especially MYH9 (i.e myosin). In patients 
that carry mutations within the MYH9 gene macrothrombocytopenia occurs, 
due to a reduced myosin activity (Althaus K & Greinacher A. 2009). MYH9 
deficiency attenuates the initial proplatelet formation within the bone marrow 
due to a defective Rho-Rho kinase-myosin IIA signaling pathway that results in 
reduced circulating platelet counts (Chang et al., 2007; Chen et al., 2007). In 
this context, RUNX1, a transcription factor, has been found to regulate the 
MYH9 gene expression which may explain the familial platelet disorders in the 
acute myelogenous leukemia patients, some of whom exhibit a germline 
heterozygous RUNX1 gene mutation (Bluteau D, et al. (2012). 
Nowadays, the progress of live imaging by multiphoton microscopy 
facilitates the visualization of proplatelet formation in vivo. Junt et al. were first 
to visualize platelet production in vivo (Junt T. et al., 2007). Afterwards, Zhang 
et al. have demonstrated that sphingosine 1-phosphate (S1P) signaling 
through its receptor S1pr1 facilitates the guidance of proplatelets into the blood, 
likely through the regulation of Src family kinases in MKs (Zhang L. et al., 
2014). Recently, a group showed that a different and atypically formed platelet 
generation is higher under an acute platelet need or inflammatory condition. 
Their data show that MKs can undergo a rupture like disintegration step to 
rapidly release huge numbers of platelets to cover the platelet demands under 
inflammatory conditions. As a possible underlying mechanism, they identified 




platelet biogenesis requires the activation of intracellular caspases is still 
controversial. Nonetheless, a recent study found that IL-1α signaling through 
its designated receptor activate caspase-3 that leads to a reduction of 






Fig.2.5 Regulation of TPO production (Benjamin T Kile, 2015). 
 
2.5 Conclusion 
During thrombopoiesis, proplatelet generation and release occur in a tightly 
regulated spatial-temporal manner. Within the bone marrow megakaryocytes 
reside within a very complex niche, in close proximity to various kinds of 
hematopoietic and immune cells, particularly with neutrophils. However, up to 
now only little is known about the functional relevance of a direct or indirect 
MKs-leucocytes interaction and its role on thrombopoiesis. Hence, this project 
attempts to investigate the leukocytic effects on thrombopoiesis and provides 
us a new concept about whether and how immune cells are involved in the 






3. Materials and methods 
 
3.1 Mice strains 
 
C57BL/6 mice were purchased from Charles River company. Pf4-Cre mice 
(Tiedt, Schomber et al. 2007), Rosa26-Confetti mice (Livet J; et al. 2007), 
Lysm-eGFP mice (Faust N, et al. 2000), CD41-eYFP mice (Zhang J, et al. 
2007) were purchased from the Jackson laboratory. Rosa26idtr_Mrp8Cre mice, 
Mrp8Cre_CXCR4flox/floxtransgenic mice, and Mrp8Cre_CXCR4flox/flox_Lysm-eGFP 
mice were kindly provided by Prof. Andrés. Hidalgo. P22phox mutated mice 
were kindly provided by Prof. Görlach. To generate 
Rosa26-Confetti_Pf4Cre_Lysm-eGFP triple knock in mice, we first crossed the 
Rosa26-Confetti mouse with Pf4Cre mouse line before being crossed with 
Lysm-eGFP mouse line. All animal experiments were approved by the 
Bavarian government and met the demands of Bavarian legislation concerning 





Name Clone Company Catalog number 
Ultra-LEAF Purified anti-mouse 
Ly-6G Antibody 
1A8 Biolegend 127649 
Ultra-LEAF Purified Rat IgG2a, 
κ Isotype Ctrl Antibody 
RTK2758 Biolegend 400544 




anti-mouse Ly6G/Ly6C (Gr-1) 
Ultra-LEAF™ Purified 
anti-mouse CD11a Antibody 
M17/4 Biolegend 101118 
FITC Hamster Anti-Mouse 
CD61 
HMβ3-1 BD Pharmingen 553346 
FITC Rat Anti-Mouse CD3 
Molecular Complex 
17A2 BD Pharmingen 555274 
FITC anti-mouse CD41 
Antibody 
MWReg30 Biolegend 133904 
FITC Rat IgG1, κ Isotype Ctrl 
Antibody 
RTK2071 Biolegend 400405 
FITC Hamster IgG1 κ Isotype 
Control A19-3 
A19-3 BD Pharmingen 553971 
PE anti-mouse CD115 
(CSF-1R) Antibody 
AFS98 Biolegend 135506 
PE Rat Anti-Mouse Ly-6G 1A8 BD Pharmingen 551461 
PE anti-mouse CD41 Antibody MWReg30 Biolegend 133906 
PE Rat IgG1, κ Isotype Ctrl 
Antibody 
RTK2071 Biolegend 400408 
APC anti-mouse Ly-6G/Ly-6C 
(Gr-1) Antibody 
R86-8C5 Biolegend 108412 
APC anti-mouse/rat CD42d 
Antibody 
1C2 Biolegend 148506 
CD45R (B220) Monoclonal 
Antibody, PE-Cyanine5 
RA3-6B2 eBioscience 15-0452-82 
CD144 (VE-cadherin) 
Monoclonal Antibody, Biotin 
16B1 eBioscience 13-1449-82 
GFP Polyclonal Antibody  Invitrogen A-11122 






Name Company Catalog number 
Thiazole Orange Sigma-Aldrich 390062 
Recombinant Mouse Thrombopoietin Immunotools 12343615 
Neutrophil Isolation Kit, mouse Miltenyi Biotec 130-097-658 
Monocyte Isolation Kit (BM), mouse Miltenyi Biotec 130-100-629 
Pan T Cell Isolation Kit II, mouse Miltenyi Biotec 130-095-130 
LD Columns Miltenyi Biotec 130-042-901 
Dulbecco’s Modified Eagle’s Medium Sigma-Aldrich D8537 
L-15 Medium (Leibovitz) Sigma-Aldrich L1518 
EZ-Link™ Sulfo-NHS-Biotin Thermo Scientific 21217 
Apocynin Sigma-Aldrich A10809 
Qtracker 705 Vascular Labels Invitrogen Q21061MP 
 
3.2.3 Machines and software	
 
Name Company Version 
Centrifuge Eppendorf 5804R 
Two photon microscope LaVision Biotec TriM Scope II Series 
Confocal microscopy Zeiss LSM 900 
Hematology analyzer IDEXX ProCyte Dx 




Cryotome Lecia CryoStar NX70 
Prism Graphpad Prism 7 
IMARIS software IMARIS 7.2.1 and 8.2.1 




3.3.1 Neutrophil depletion in mice 
For neutrophil depletion in Rosa26idtr/Mrp8Cre mice, diphtheria toxin (DT), 
which was prediluted with PBS to achieve a final dose of 10ng/g bodyweight, 
was intraperitoneally (i.p) injected. Each mouse received a consecutive 5-days 
treatment with DT. 
For antibody mediated neutrophil depletion, 10-12 weeks-old C57BL/6 
mice, Confetti-PF4Cre/Lysm-eGFP or CD41eYFP mice received intravenously 
(i.v) 50μg Ly6G purified antibody (clone RB6-8C5) or isotype control every 
second day for three times. 
 
3.3.2 Multiphoton intravital live imaging 
The preparation of the calvaria bone was described before (Zhang L. et al., 
2014). First, 10-12 weeks-old mice received an anesthesia with 5.0 Vol. % 
Isoflurane and 2% oxygen, followed by an i.p. injection of MMF solution (90μl 
Midazolam (0.5mg/kg), 90μl Fentanyl (5mg/kg) and 15μl Meditomidin 
(0.05mg/kg)) with a repetitive injection every 45 min. Next, hair on the head 
was removed by a shaver and hair removal solution (MAXIM, Köln Germany). 
Afterwards a PE-10 polyethylene catheter was placed into the murine tail vein 




on the front calvarium and exposure of midline and frontoparietal skull, a 
custom metal ring was immobilized on the skullcap with metal glue which 
allowed the application of PBS or ultrasound gel respectively to prevent tissues 
drying during imaging. The mouse head was immobilized with custom metal 
holder and the mouse was placed on a heating pad to maintain body 
temperature. A LaVison Biotech intravital multiphoton scope system based on 
Ti:sa laser and OPO laser, equipped with a 16X water immersion objective, NA 
0.95 (Nikon, Germany) was used to visualize the mouse calvarium and to 
capture images. In Confetti_Pf4Cre_Lysm-eGFP mouse model, eGFP 
fluorescence and confetti fluorescence (particular RFP) were detected by Ti:sa 
laser with an 800nm wavelength and OPO laser with a 1050nm wavelength. In 
CD41YFP-Ly6G-PE mouse model, YFP fluorescence and PE-labeled 
neutrophils were detected by a compromised 910nm wavelength. The 
vasculature was visualized by administration of 15μl Qtracker705; which was 
detected in 800nm with a near infrared channel (US695/H). For 4 dimensional 
image acquisition, image stacks were captured at an aforementioned 
wavelength with a 1-2μm imaging depth per layer over a total depth of 
20-50μm with a plan region of interest of 405×405μm every 60 seconds over 
1hour. To generate and analyze 4D movies, original data were reconstructed 
by IMARIS software (version 7.2.1 and 8.2.1). Following parameter will be 
determined: number of MK-leukocyte interactions, interaction times, 
proplatelet length, releasing time and speed. To analyze the sphericity of MKs, 
the surface of MKs was constructed by IMARIS software based on the 
fluorescence of MKs. The sphericity of MKs can be automatically analyzed by 
the IMARIS software. 
 




Fetal liver cell derived megakaryocytes were generated from fetal livers 
(E13.5-14.5) which were subsequently cultured in Dulbecco’s Modified Eagle 
Medium (DMEM; Invitrogen, Germany) with supplementary of 10% Fetal 
bovine serum, 1% penicillin and streptomycin and 70ng/ml mouse 
Thrombopoietin (mTPO) for 4-5 days to acquire mature megakaryocytes in the 
humidified 5% CO2 incubator at 37℃ as previously described (Jonathan N. 
Thon, et al. 2010). Subsequently mature MKs were purified and enriched using 
a bovine serum albumin (BSA) gradient (from top to bottom, 
PBS-1.5%BSA-3%BSA) before being harvested after 30 minutes from the 
sediment. 
Similarly, in order to acquire the bone marrow derived megakaryocytes, 
adult mouse bones were harvested and bone marrow was flushed with 2% 
FBS/PBS. Bone marrow suspension was cultured for 4-5days in Dulbecco’s 
Modified Eagle Medium (DMEM; Invitrogen, Germany) with a supplementary 
of 10% Fetal bovine serum, 1% penicillin/streptomycin and 70ng/ml mouse 
Thrombopoietin (mTPO) as well as 15UI/ml heparin. At day 4 cells were 
collected with the same BSA gradient method as aforementioned. 
 
3.3.4 Measurement of reticulated platelets 
Murine whole blood was collected by cardiac puncture using an ACD 
buffer treated tube. 20μl whole blood was fixed with 1% PFA at room 
temperature for 10 minutes and thereafter washed with PBS in a 15ml falcon. 
Platelets then were stained in 100μl PBS with 1μg/ml thiazole orange and 1μl 
CD42d-APC. Afterwards the population of reticulated platelets was gated and 
determined by thiazole orange and CD42d-APC double positive.   
 




Mice were intravenously injected with Sulfo-NHS-Biotin (30mg/kg) 
(Thermofishcer, Gemany) through the lateral tail vein. Beginning at day one 
after biotinylation, 20μl blood was collected from the tail vein in ACD (Acid 
citrate dextrose) buffer, diluted into 100μl PBS buffer and stained with 1μl 
CD42d-APC antibody and 1μl streptavidin-PE antibody at 4℃ in a dark place 
for 30 minutes. The fraction of biotinylated streptavidin bound platelets was 
detected after gating for CD42d positive platelets. At day one 100% of platelet 
were streptavidin positive, though the percentage of this cell population 
decreased over time, Platelet lifespan was determined by linear regression 
analysis. 
 
3.3.6 Neutrophils adoptive transfer  
Mouse bones were collected from donor C57BL/6 mice or genetic knock 
out mice. For PMN homing experiments, neutrophils were harvested from 
Lysm-eGFP mice or Mrp8CXCR4/Lysm-eGFP mouse which express enhanced 
green fluorescent proteins in PMN.  
For isolation bones were cut at the end and bones marrow was flushed with 
2%FBS/PBS. After collection of the bone marrow, neutrophils were isolated 
according to the manuals of mouse neutrophils isolation kit (Miltenyi biotec, 
Germany). Afterwards, 2.500.000 neutrophils were injected via lateral tail vein 
into recipient mouse. One hour after the adoptive transfer, the recipient mice 
were sacrificed and perfused with PBS and 4% PFA. Thereafter mouse 
femoral, humoral and tibia bones from recipient mice were harvested and then 
incubated firstly in 15% sucrose and 30% sucrose, sequentially. Finally, bones 






3.3.7 Whole mount bone staining 
Frozen Bones were cut horizontally. Next bones were blocked in a 10% 
goat serum with 0.1% triton X-100 for 1 hour at room temperature. Thereafter 
bones were incubated in PBS with primary antibodies overnight to label 
transferred neutrophils, vessels and megakaryocytes, respectively. After 
incubation and washing, bones were visualized by confocal microscopy or 
multiphoton microscopy. 
 
3.3.8 Quantification of platelet associated fragments  
Sterile 6 well plates were coated with 100µg/ml fibrinogen at 37℃, for one 
hour and blocked with 1.5% BSA afterwards. Megakaryocytes and neutrophils 
were isolated using the BSA gradient method or PMN isolation kit (Miltenyi 
biotec, Germany) as mentioned above. In order to measure the impact of 
neutrophils on the release of platelet associated fragments, a different 
numbers of megakaryocytes (10.000, 25,000 and 50,000) were seeded in the 
6 well plates and then co-cultured with 2.500.000 neutrophils in culture- 
medium (40% DMEM medium+10%FBS+1% penicillin/streptomycin) + 60% 
L-15 medium) for 6 hours at 37℃. After 6 hours, the supernatant of each well 
was collected and fixed with 1%PFA for 10 minutes. After washing with PBS, 
the pellet was stained with 1:100 concentration of CD42d-APC, CD61-FITC 
and Ly6G-PE antibody mix. 
 
3.3.9 Immunostaining 
Coverslips were washed with ethanol and distilled water sequentially 
before being coated with 100ng/ml fibrinogen. Megakaryocytes and 
neutrophils were seeded on the coverslips and co-cultured in the mix medium 




medium) at 37℃ for 6 hours. Thereafter cells were fixed with 4% 
paraformaldehyde for 10 minutes and then washed with PBS. All the cells 
were permeabilized with 0.1% NP40 for intracellular protein staining. Cells 
were incubated with different primary antibodies at room temperature for 2 
hours or 4℃ overnight and then in secondary and conjugated antibodies for 2 
hours at room temperature. Primary antibodies and secondary antibodies 
included Ly-6G purified antibody (Biolegend, San Diego, USA), CD144 
antibody (Biolegend, San Diego, USA), CD41-FITC antibody, Stromal 
cell-derived factor-1 antibody (Cell signaling technology, Massachusetts, USA) 
 
3.3.10 Blood count measurement 
Mouse blood was harvested by cardiac puncture, collected in an ACD 
buffer tube (the ratio between ACD and blood is 1:7) and analyzed by a 
hematology system (IDEXX ProCyte DX). 
Human blood samples from healthy donors were drained by venous 
puncture using a specified single-use citrate pretreated container (Sarstedt) 
and measured in an automatic hematocytometer system in Klinikum der LMU 
München. 
 
3.3.11 Flow cytometry and cell sorting 
 Cells was surface stained in FACS buffer (PBS supplemented with 2% 
FBS) on ice for 30 minutes. Multiparameter flow cytometric analysis was 
performed using a Gallios Flow Cytometer (Beckman Coulter). Neutrophils 
were gated by Ly6G. T cells and B cells were gated by CD3 and CD45R, 
respectively. Monocyte population was identified by GR-1high, CD115high. 
Following antibodies were used: Ly6G-PE(1A8), CD3-FITC (17A2), 




3.3.12 LFA-1 antibody blocking experiment 
For the LFA-1 blocking experiment, 10-12 weeks-old C57BL/6 mice 
received 50μg CD11a purified antibody (clone M17/4) or isotype control 
antibody intravenously (i.v) every second day, three times in total.  
 
3.3.13 Statistics analyses 
Data was analyzed using Prism7 (GraphPad) and presented as mean SEM 
(standard error of mean). A p-value <0.05 was considered as statistically 
significant. Student’s t test was used for two groups comparison. Statistics 
analysis of multiple group comparison based on the One-way ANOVA followed 






















4.1 The absence of neutrophil in vivo attenuates the platelet 
production 
 
4.1.1 Diphtheria toxin (DT) induced neutrophil depletion in 
Rosa26iDTR_Mrp8cre mice results in reduced platelet counts  
 
In order to investigate the role of leukocytes, in particular of neutrophils, in 
thrombopoiesis in vivo, we first used Rosa26iDTR/Mrp8cre mice, which express 
diphtheria toxin receptor under control of a neutrophil specific Mrp8 promotor, 
to see how platelet counts change within the peripheral blood under an acute 
neutropenic condition. 
 A consecutive 5 day treatment with diphtheria toxin (DT) (0.01μg/g 
bodyweight) almost entirely abolished peripheral neutrophils within the 
bloodstream (Fig.4.1.1.2). Meanwhile, white blood cell counts showed a 35% 
decrease and platelet counts also presented a 30% decline in mice, showing a 
thrombocytopenic phenotype (Fig.4.1.1.2). The thrombocytopenic phenotype 
indicated either the platelet production or clearance altered after induction of 
neutropenia. Hence, the reticulated platelets (young platelets) were assessed 
with flow cytometry technique by gating the thiazole orange and CD42d-APC 
double positive population in all blood cells. The reticulated platelet fractions 
showed a reduction in the absence of neutrophils (Fig.4.1.1.3), indicating the 
platelet biogenesis was to some extent blunted. In the meantime, the platelet 
lifespan in the course of treatment were also similar in both groups 
(Fig.4.1.1.4). The percentage of biotinylated platelets had no significant 




not affect the cell -involved (i.e. Macrophages) platelet clearance. The number 
of mature MK is also of importance to determine the platelet production in the 
mouse. The flow cytometric assessment of MK progenitors or mature MKs in 
the bone marrow did not show relevant difference in both groups as well 
(Fig.4.1.1.5). Worth mentioning, a previous study has demonstrated that 
mature MKs with high content of DNA are susceptible to produce platelets. 
Hence, MKs ploidy measurement is also useful and necessary to examine MK 
maturation after 5 days DT treatment. Based on our flow cytometry analysis 
(Fig.4.1.1.6), MK ploidy likewise did not show relevant difference in these two 
groups. The data of above-mentioned two assessments indicated neutrophil 
depletion would not affect the megakaryopoiesis. Taken together, we 
concluded that the absence of neutrophils in mice impacts on thrombopoiesis 













Fig.4.1.1.2 Diphtheria toxin (DT) treatment results in a marked reduction 
of platelet counts in Mrp8-Cre positive mice  
blood analyzed at day5, N=4 per group, error bars, mean±SEM *P<0.05, 
**P<0.01, ****P<0.0001, data represent two independent experiments 






















































































Fig.4.1.1.3 Circulating reticulated platelet fragments (young platelets) 
assessed by flow cytometry with thiazole orange staining  
N=4 per group, error bars, mean±SEM *P<0.05, **P<0.01, data represent two 






Fig.4.1.1.4 Assessment of platelet lifespan in Mrp8Cre+ and Mrp8Cre- 
littermate control mice over time with DT treatment  
blood samples were collected from tail vein at the same time point of each day, 
N=4 per group, error bars, mean±SEM, n.s, (non-significant), data analyzed 



































Fig.4.1.1.5 Quantification of megakaryocytic progenitors and mature MK 
numbers in Mrp8Cre+ mice and their littermate controls after DT treatment 
N=4 per group. error bars, mean±SEM *P<0.05, **P<0.01, n.s. 
(non-significant), data representing two independent experiments analyzed 




Fig.4.1.1.6 MK ploidy assessed by flow cytometry after DT treatment  
































































































independent experiments analyzed with one-way ANOVA test. 
 
4.1.2 Antibody mediated neutrophil depletion leads to a 
thrombocytopenic phenotype 
 
 To verify that the collected data was not mouse-specific, we performed a 
widely used neutropenic mouse model by Ly6G/Ly6C (clone RB6-8C5) 
antibody mediated neutrophil depletion in C57BL/6 mice. The same treatment 
scheme of DT induced neutropenia was adopted (Fig.4.1.2.1). Within this 
model, the application of Ly6G/Ly6C antibody induced the reduction of WBC 
and neutrophil counts in peripheral blood (Fig.4.1.2.2). Interestingly, platelet 
counts displayed a continuous decline about 23% on day 3 and 30% on day 5 
in comparison to their littermate controls (Fig.4.1.2.2). And this data indicated 
that the reduction of platelet counts under neutropenic condition was indeed 
time- and neutrophil-dependent. Thereafter we assessed the reticulated 
platelet fractions on day 0, day 3 and day 5, respectively (Fig.4.1.2.3). The 
platelet counts did not show a drastic drop followed by continuing neutrophil 
depletion on day 5, but reticulated platelet production still remained low yield 
on day 5. In analogy, platelet lifespan assays demonstrated that neutrophils do 
not alter platelet clearance in the time course of antibody induced neutropenia 
(Fig.4.1.2.4). Mature MK counts and MK maturation (i.e. ploidy) were not 
affected by this neutrophil depletion antibody as well according to our flow 
cytometry analyses (Fig. 4.1.2.5 and Fig. 4.1.2.6). Moreover, maximal MK 
diameter and MK counts in the humeral bones were assessed by using 
multiphoton microscopy imaging techniques, and no phenotypic changes of 
MKs were found in both two groups, indicating no alteration of 
megakaryopoiesis within this neutropenic model. In combination with the data 









Fig.4.1.2.1 Ly6G/Ly6C antibody treatment scheme in C57BL/6 mice  
 
 
Fig.4.1.2.2 Antibody mediated neutrophil depletion leads to reduced 
platelet counts in C57BL/6 mice  
N=4-7 per group, error bars, mean±SEM, ***P<0.001, ****P<0.0001 n.s 
non-significant, data represents 3 independent experiments analyzed with 
























































Fig.4.1.2.3 Reticulated platelet production is attenuated after neutrophil 
depletion  
N=3-5 per group, error bars, mean±SEM *P<0.05, **P<0.01, n.s 
non-significant, data representing 2 independent experiments analyzed with 




Fig.4.1.2.4 Platelet lifespan did not change during the time course of 
treatment by Ly6G/Ly6C depletion antibody  

























































Fig.4.1.2.5 Quantification of mature MK numbers by FACS in C57BL/6 
mice  
N=7, error bars, mean±SEM, n.s not significant, data representing 3 



































































On day 5, MK ploidy was assessed by quantification of propidium iodide 
intensity. N=4, error bars, mean±SEM *P<0.05, **P<0.01, n.s non-significant, 








Fig.4.1.2.7 MK characterizations after antibody induced neutropenia in 
C57BL/6 mice  
(A) representative whole-mount picture of humeral bones (B) MK number 
quantification (C) and maximal diameter of MKs were analyzed by IMARIS 
software (N=3, error bars, mean±SEM *P<0.05, **P<0.01, n.s non-significant, 















































Next we wanted to investigate the leukocyte subsets specificity of our 
findings. Therefore we took advantage of a catchup mouse line. The catchup 
mouse is a kind of genetic mouse in which Ly6G locus is modified with a 
knock-in allele encoding Cre recombinase and the tdTomato fluorescent 
protein. Neutrophils show no Ly6G expression in homozygous mice and 50% 
more expression in the heterozygous ones.  
To exclude side- and off-target effects of Ly6G/Ly6C antibody (RB6-8C5 
clone) in mice, the same neutrophil depletion strategy was adopted in catchup 
mice (Fig.4.1.3.2). As figure 4.1.3.3) shows, WBC and neutrophil counts 
decreased in the bloodstream of heterozygous mice as usual and platelet 
counts also showed a decline. In contrast WBC and neutrophil counts remain 
stable after Ly6G/Ly6C antibody treatment in homozygous mice due to the 
deficiency of Ly6G on neutrophils. Importantly, platelet counts did not change 
over time. This data once again demonstrated PMN was the reason that 
resulted in reduced platelet yields in the mouse. 
 
 
Fig.4.1.2.8 Representative of targeting strategy for the generation of 








Fig.4.1.2.9 Ly6G/Ly6C antibody treatment scheme in catchup mice 
 
 
Fig.4.1.2.10 Antibody mediated neutrophil depletion leads to reduced 
platelet counts in catchup heterozygous mice, but not in homozygous 
ones (N=3-4, error bars, mean±SEM *P<0.05, **P<0.01, data analyzed with 
unpaired Student’s t-test). 
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4.2.1 Augment PAF release from MKs in vitro 
 
Based on our data from both murine acute neutropenia models, we 
demonstrated that neutrophils play a prominent role during the final steps of 
platelet biogenesis in vivo. Given the intrinsic limitation and complexity of 
MK-PMN interaction in vivo, we established an in vitro co-culture model 
(Fig.4.2.1.1 and Fig.4.2.1.2) to examine and investigate the effects of 
molecules or cell types on thrombopoiesis. 
Sphingosine 1-phosphate (S1P) has been identified as an agonist that 
can amplify the MKs’ proplatelet fragmentation in vivo and in vitro (Zhang L. et 
al., 2014). Hence we verified this results by treating MKs with 10μM S1P, after 
6 hours co-culturing, bone marrow derived MKs (Fig.4.2.1.3) yielded increased 
PAF numbers when stimulated by S1P alone and importantly when co-cultured 
with PMNs. We further tested the impact of different ratios between MK and 
neutrophil numbers. Indeed, we found that PAF number decreased with lower 




Fig.4.2.1.1 Schematic overview of in vitro co-culture procedure. 









Fig.4.2.1.2 Bright field microscopy image of a bone marrow derived MK 
interactions with PMNs in vitro  












































after MK-PMN co-culture 
PAF counts of indicated co-culture MK(k, thousand) - PMN(250,000) groups 
were normalized before comparison with vehicle group(blue), N=4, error bars, 
mean±SEM *P<0.05, **P<0.01, n.s non-significant, data representing 4 
independent experiments, One-way ANOVA followed by Tukey’s multiple 
comparison test was used to determine the statistical significance. 
 
4.2.2 Impact of different white blood cell (WBC) populations on PAF 
generation 
 
   Given that different population of white blood cells are found in the 
peripheral blood as well as within the bone marrow, it was essential to examine 
the effects of other WBCs on thrombopoiesis (i.e. lymphocytes). We adopted 
our in vitro co-culture model to examine the effects of other cell types on PAF 
production. Hence we examined the effect on the role of T-cells and 
monocytes by seeding either pan-T cells or monocytes (250,000 cells) on top 
of the MKs. Of note the number of monocytes and lymphocytes within the BM 
is lower than PMN numbers hence the in vitro ratio between either cell type 
and MKs may by overestimated in our model. As shown in Figure.4.2.1.4
monocytes augmented PAF numbers in the supernatant, while T-cells have no 
effect on PAF formation. The effect of monocytes was robust for all three 






(data share by Christian Weber) 
 
Fig.4.2.1.4 Flow cytometric quantification of PAF counts in the 
supernatant after co-culture with indicated WBC subsets  
N=3-4, error bars, mean± SEM. *P<0.05, ***P<0.001, n.s non-significant, data 
representing 4 independent experiments, One-way ANOVA followed by 
Tukey’s multiple comparison test was used to determine the significance. 
 
4.2.3 A physical interaction between PMNs and megakaryocytes is 
required to promote PAF release in vitro 
 
Cell-to-cell communications occurs through direct physical interaction or 
paracrine mechanisms mediated by cytokines or chemokines respectively. To 
address which mechanism contributes to PAF formation in our setting we 
performed trans-well assays. Hence, a Boyden chamber assay was 
established to examine whether neutrophils accelerated proplatelet forming 
through direct physical interactions. An insert with a pore size of 0.4μm was 














































interactions (Fig.4.2.3.1). As done before the same number of neutrophils was 
seeded in the upper chamber. Our data suggest that released cytokines or 
chemokines do not increase PAF number in vitro but rather require a direct 
physical interaction.  
To further elaborate on this question MKs were cultured in supernatant of 
phorbol myristate acetate (PMA) stimulated PMNs. However supernatants 
also did not show a PAF-augmenting capacity, underscoring that neutrophils 
derived cytokines or chemokines are not necessary for the PAF release in our 
in vitro assay.  
 
 
      (data shared by Christian Weber) 
 
Fig.4.2.3.1 Flow cytometric analysis of PAF counts in a modified 
tran-swell model  
A trans-well chamber with a pore size 0.4μm containing neutrophils on the top 
and MKs were seeded in the bottom of six wells. N=3, error bars, mean±SEM 
*P<0.05, **P<0.01, ***P<0.001, n.s non-significant, data representing 3 
independent experiments, One-way ANOVA followed by Tukey’s multiple 
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4.2.4 Inhibition of PMN mobility reduced the effects of PMNs on PAF 
release 
 
We found that neutrophil mediated platelet fragmentation in vitro needs a 
direct physical interaction with MKs. Hence, the inhibition of PMN migration or 
other motile actions should decrease PAF release in vitro. Therefore, we 
repeated our co-culture experiment following PMN treated with cytoskeleton 
protein inhibitors, like cytochalasin D, Blebbistatin and nocodazole. The fungi 
toxin Cytochalsin D specifically inhibits actin polymerization by 
depolymerizingd the actin filament organization. Blebbistatin is widely used to 
selectively inhibit the activity of myosin II ATPase and to blunt the cell motility 
functions. Nocodazole is an agent, that exerts effects in cells by interfering with 
the microtubule polymerization and is commonly used in oncology. 
    Neutrophils were pre-incubated with 100nM Cytochalsin D, 50nM 
Blebbistatin and 50nM Nocodazole, respectively, for 30 minutes before being 
co-cultured with MKs. As shown in Fig.4.2.4.1, neutrophils treated with 
Cytochalasin D and Blebbistatin lost their function of PAF augmentation in vitro 
with comparison to sham and Nocodazole, which may be due to the defect of 
physical interaction with MKs. This data also suggested that actin-myosin 








Fig.4.2.4.1 Flow cytometric quantification of PAF number in vitro model 
co-culture with cytoskeletal protein inhibitors treated PMNs  
N=3, error bars, mean±SEM *P<0.05, **P<0.01, n.s non-sifnificant, data 
representing 3 independent experiments, One-way ANOVA followed by 
Tukey’s multiple comparison test was used to determine the significance. 
 
4.3 Proplatelet fragmentation in vivo is attenuated in the 
absence of PMNs 
 
4.3.1 PMN-MK interactions occur more frequently with highly 
proliferative MKs 
 
Previous data has demonstrated positive effects of neutrophils on platelet 
biogenesis in vivo and vitro. So far we do not know how effect thrombopoiesis 
in vivo. Therefore, we established a calvarium imaging model to visualize 
physical MK-PMN interactions in vivo to characterize interaction dynamics.   












































the CD41eYFP mouse 30 minutes before the imaging. CD41eYFP reporter 
gene mice express enhanced yellow fluorescence in megakaryocytes. In our 
preliminary test, Ly6G-PE antibody was able to label neutrophils in peripheral 
blood and the bone marrow approximately one hour after injection 
(Fig.4.3.1.2). Hence, using multiphoton intravital microscopy (MP-IVM) the 
neutrophils (red) and megakaryocytes (yellow) could be clearly distinguished 
and visualized within the calvarial bones and bloodstream (Fig.4.3.1.3).  
By using this model, we visualized the physical interactions between 
neutrophils and MKs with different maturity and tried to characterize their 
interaction patterns. In order to better characterize MKs a mathematic 
parameter, Waddell sphericity index (" =
!!(6VP)23
AP ), was introduced to 
describe the angularity of the observed objects. The Waddell sphericity index 
ranges from 0 to 1. The sphericity value of MKs displays an inverse 
relationship of cell angularity, meaning that more angulated proplatelet-forming 
MKs have a lower sphericity (Fig.4.3.1.4A). In CD41eYFP mouse, MKs 
showed a gaussian distribution of their sphericity (Fig.3.3.1.5A). However, we 
found that PMN interact with all different categories of the MKs (Fig.4.3.1.4B). 
Moreover, the ratio analyses of proplatelet-forming MK (PPF MK) to none 
proplatelet-forming MK (None-PPF MK) suggested that low sphericity MKs had 








Fig.4.3.1.1 The schematic overview of CD41eYFP/Ly6G-PE antibody dual 
reporter model  
CD41eYFP mouse received one dose (5 g) of PE labeled Ly6G (clone 1A8) 




Fig.4.3.1.2 Gating strategy of bone marrow PMNs in Lysm-eGFP mouse 1 
hour after Ly6G-PE i.v injection  





this population can be sorted in bone marrow indicates Ly6G-PE is able to 





Fig.4.3.1.3 Representative image of MK-PMN interactions in carvarial 
compartment of CD41eYFP/Ly6G-PE mouse  













(A) representative 3D reconstructed picture of MKs with different Waddell 
sphericity indices and (B) a representative image, reconstructed from a video 
of CD41eYFP/Ly6G-PE dual reporter mouse (6 layers, 18μm depth) (MKs, 
PMNs and vessels are shown in green, red and cyan colors, respectively. 





Fig.4.3.1.5 Sphericity indices can be used to discriminate MK 
proliferation in vivo 
(A) MKs display a gaussian distribution (B) Highly proliferative, proplatelet 
forming MKs have lower sphericity indices (<0.5), low proliferative, round MKs 










































































Fig.4.3.1.6 Quantification of MK-PMN interaction time and interacted PMN 
numbers in CD41eYFP/Ly6G-PE model  
(A) mean time of each PMN and (B) mean number of PMNs interacted with 
each MK during the in vivo imaging (8 videos and 40 MKs were analyzed, error 
bars, mean±SEM *P<0.05, **P<0.01, data represents 8 independent 
experiments analyzed with One-way ANOVA followed by Tukey’s multiple 
comparison test).  
 
4.3.2 Proplatelet formation dynamics in vivo  
 
Our data demonstrated that antibody mediated neutrophil depletion can 
lead to reduced platelet counts through blunting the platelet biogenesis in mice. 
To further elaborate on this, we visualized proplatelet formation during the 
thrombopoiesis in the presence or absence of neutrophils. As usual, we firstly 
demonstrated that antibody-mediated neutrophil depletion yields reduced 
platelet counts in CD41eYFP mice (Fig.4.3.2.1). Thereafter we visualized 






























































































presence of neutrophils. In the control group, proplatelet growth was constant 
without any retractions. In contrast, under neutropenic condition, proplatelet 
growth was slower and the release was delayed, did repetitive retraction of the 
proplatelet.  
In detail (Fig.4.3.2.2), the number of proplatelets released by MKs per 
hour was less in the absence of neutrophils; due to an increased proplatelet 
releasing time. However, the maximal length of proplatelet, displayed no 
statistically significant difference between the two groups, indicating that the 
absence of neutrophil would not impact on the MK proplatelet forming, rather 
on proplatelet releasing and shedding speeds. In a second approach we used 
another reporter mouse model (Confetti Pf4/Lysm-eGFP mouse) to visualize 
the PMN-MK interactions during thrombopoiesis (Fig.4.3.2.3). Again under 
neutropenic conditions proplatelet releasing times were prolonged and the 
amount of released proplatelets was reduced. However, as seen before the 
maximal length of proplatelets showed no significant difference in both groups. 
Interestingly, MK-PMNs interaction decreased within the vasculature niche but 
not within the bone marrow niche. This is in line with our observation from our 
RosaiDTR_Mrp8cre mouse model which showed that an additional abolishment 
of neutrophils inside the BM niche does not lead to an increase in platelet 
reduction beyond the observed 30%, seen within the antibody depletion model. 
Taken together, this finding suggested a dominant role of PMN-MK within the 








Fig.4.3.2.1 Peripheral blood counts in CD41eYFP mice after 3 times 
antibody mediated neutrophil depletion  
N=3-4, error bars, mean±SEM *P<0.05, **P<0.01, data represents 2 






























































































































































































Fig.4.3.2.2 Quantification of MK proplatelet formation in 
CD41eYFP/Ly6G-PE antibody dual reporter model under steady and 
neutropenic conditions.  
N=3-4, error bars, mean±SEM *P<0.05, **P<0.01, NS, not significant, data 
represents 7 independent experiments analyzed by IMARIS software and 
statistical significance was determined with unpaired Student’s t-test. 
 
 
4.4 Spatial resolution of PMN-MK interactions during 
thrombopoiesis 
 
4.4.1 PMNs within the vascular niche drive proplatelet fragmentation  
 
To assess the role of PMNs in circulation pool, in a second approach we 
used another reporter mouse model (Confetti Pf4/Lysm-eGFP mouse) to 
visualize the PMN-MK interactions during thrombopoiesis (Fig.4.4.1A). In 
confetti Pf4/Lysm-eGFP mouse, cell intrinsically express red fluorescence in 
MKs and green fluorescence in PMN cells under the control of Pf4 promotor 
and Lyz2 promotor, respectively. Again under neutropenic conditions 
proplatelet releasing times were prolonged and the amount of released 
proplatelets was reduced. However, as seen before the maximal length of 
proplatelets showed no significant difference in both groups. Interestingly, 
MK-PMNs interaction decreased within the vasculature niche but not within the 
bone marrow niche (Fig.4.4.1B). This is in line with our observation from our 
RosaiDTR_Mrp8cre mouse model which showed that an additional abolishment 
of neutrophils inside the BM niche does not lead to an increase in platelet 




Taken together, this finding suggested a dominant role of PMN-MK within the 
vascular nice on thrombopoiesis. 
 In the absence of neutrophils (neutrophil elimination only in the circulation) 
over 5 days platelet counts are progressively decreasing in C57BL/6 mice 
displayed a progressively decreasing trend (reduced by 23% and 30% at day 3 
and 5, respectively). Rosa26iDTR x Mrp8Cre mice also exhibited a 30% reduction 
in platelet counts under neutropenic conditions for constitutive 5 days. 
However, neutrophil elimination in both BM and vasculature pools in 
Rosa26iDTR x Mrp8Cre mice did not show additional platelet reduction or 
deterioration of their thrombocytopenic phenotype in the mouse. Video 
analysis found that most neutrophils in the circulation locate to the budding 
sites of proplatelet forming megakaryocytes (Fig.4.4.2). These data might 
indicate that bone marrow resident neutrophils are less important compared to 
neutrophils within the vascular niche. In particular, adhesive neutrophils 
surrounding the budding sites of proplatelet forming MKs (dash circles area in 









Fig.4.4.1 Quantification of proplatelet formation in Confetti 
PF4/Lysm-eGFP dual reporter model under steady and neutropenic 
conditions.  
(A) representative images of proplatelet forming process under steady or 
neutropenic condition; (B) Analysis of proplatelet releasing numbers, time, 
growth speed, and interacted PMN numbers in circulation and bone marrow 
niches. (N=3 per group, error bars, mean±SEM *P<0.05, **P<0.01, n.s not 
significant, MKs and PMNs show red and green colors, respectively. Dash line 
indicates the vessel. scale bar, 30μm, data representing 6 independent 



































































































































































































































































































































Fig.4.4.2 Representative images of neutrophils gathering around the 
budding site of PPF-MKs  
MKs and PMNs show the green and red fluorescence, respectively. Dash line 
indicates the vessel, scale bar, as indicated in the picture. 
 
4.4.2 MK-PMN interactions during thrombopoiesis are ICAM-1 dependent 
 
Above introduced data demonstrated the PMN-MK interactions in the 
vasculature niche play a pivotal role during the thrombopoiesis, especially 
those in proximity to the budding sites of proplatelet forming MKs (Fig.3.4.1) 
This observation is further underscored by flow cytometry analyses of the 
different neutrophil depletion models. To further elucidate the underlying 
molecular mechanism, we focused on known molecules which have been 
identified earlier as mediators of interaction between neutrophils, platelets or 
endothelial cells including P-selectin, integrin beta2, PSGL-1 and ICAM-1, etc. 
After the blocking these molecules in the circulation compartment, we did not 
see a significant reduction of platelet counts in vivo (data not shown), except 
for ICAM-1 blocking (Fig.4.4.2.1). ICAM-1 consists of two subunit molecules, 
CD11a and CD18. ICAM-1 can be specifically blocked by a LFA-1(CD11a) 




numbers. Meanwhile, flow cytometry analyses indicated that LFA-1 antibody 
only attenuates reticulated platelets (Fig.4.4.2.2) but not mature MK numbers 
(Fig.4.4.2.3) or MK maturation (i.e. ploidy) (Fig.4.4.2.4). Furthermore, cell 
number of other white blood cells did not show big variation within the 
bloodstream and bone marrow (Fig.4.4.2.5A and Fig.4.4.2.5B). Taken 
together, all data indicate that ICAM-1 impacts on the regulation of the 
PMN-MK interaction during the thrombopoiesis. 
 
 









































































times consecutive LFA-1 antibody blocking  
N=4, error bars, mean±SEM **P<0.01, n.s not significant, data representing 





Fig.4.4.2.2 Flow cytometric analysis of reticulated platelets fragments by 
thiazole orange staining after LFA-1 blocking 
N=4 per group, error bars, mean±SEM,**P<0.01, data representing two 



































Fig.4.4.2.3 Flow cytometric assessment of mature MK numbers after 
LFA-1 antibody blocking.  
N=4 per group, error bars, mean±SEM n.s non-significant, data representing 



















































































N=4 per group, error bars, mean± SEM, n.s not significant, data analyzed with 




Fig.4.4.2.5 Cellularity and numbers of leukocyte subsets in (A) peripheral 
blood and (B) bone marrow after LFA-1 blocking  
N=4 per group, error bars, mean± SEM n.s not significant, data representing 
two independent experiments analyzed with One-way ANOVA followed by 
Tukey’s multiple comparison test. 
 
4.5 MK-PMN interactions during thrombopoiesis are SDF-1 
dependent 
 
4.5.1 Mrp8cre x CXCR4flox/flox knockout mice show reduced platelet counts  
 
CXCR4/SDF-1 chemokine axis regulates PMN homeostasis within the BM. 
Mrp8cre x CXCR4flox/flox conditional knockout mice show a neutrophil homing 




































































































phenotype. Interestingly, this mouse line exhibited reduced platelet counts in 
the peripheral blood. Therefore, further investigation of this mouse model may 
help to decipher the underlying molecular mechanism of our findings.  
Peripheral blood counts under steady conditions were measured in Cre- 
and Cre+ mice as done before (Fig.4.5.1.1). Flow cytometry analysis revealed 
that Cre+ mouse generate less reticulate platelets in comparison to Cre- mice 
(Fig.4.5.1.2). However, platelet clearance was not affected in the absence of 
CXCR4 removal on neutrophils (Fig.4.5.1.4). Furthermore, neither counts of 
matures, MK maturation (Fig.4.5.1.3 and Fig.4.5.1.5) or any other white blood 





Fig.4.5.1.1 Peripheral blood counts in Mrp8cre+ x CXCR4flox/flox and their 
Mrp8cre- x CXCR4flox/flox littermate controls  
N=4-5 per group, error bars, mean±SEM *P<0.05, **P<0.01, ***P<0.001, data 






























































































Fig.4.5.1.2 Reticulated platelet fragments assessed by flow cytometry in 
peripheral blood of Mrp8cre x CXCR4flox/flox mouse line  
N=4-5 per group, error bars, mean±SEM *P<0.05, **P<0.01, ***P<0.001, data 




Fig.4.5.1.3 Comparison of mature MKs between Mrp8cre+ x CXCR4flox/flox 
and their Mrp8cre- x CXCR4flox/flox littermate controls  











































































































Fig.4.5.1.4 Flow cytometric assessment of platelet lifespan in Mrp8cre+ x 
CXCR4flox/flox and their Mrp8cre- x CXCR4flox/flox littermate controls   





































































Fig.4.5.1.5 MK ploidy comparison between Mrp8 Cre+ and Mrp8 Cre- mice  
N=4 per group, error bars, mean±SEM, n.s non-significant, One-way ANOVA 





Fig.4.5.1.6 Cellularity and numbers of leukocyte subsets in peripheral 
blood and BM of Mrp8cre+ x CXCR4flox/flox and their Mrp8cre- x CXCR4flox/flox 
littermate controls  
N=3, error bars, mean±SEM, ****P<0.0001, n.s non-significant, One-way 
ANOVA analysis was used for multiple group comparisons. 
 
4.5.2 MK derived SDF-1 guides PMNs to the bone marrow  
    
 Platelets and MKs have been reported as reservoir of SDF-1 but whether 
MKs are also capable of attracting neutrophils is unknown. Hence, we firstly 
examined the expression of SDF-1 in the PPF MKs by confocal microscopy. As 

































































































differentiated MKs, in particular on proplatelet shafts. In order to confirm our 
hypothesis that MKs are able to attract PMNs towards the budding site during 
the thrombopoiesis, we adoptively transferred 2.5 million PMNs isolated from 
Mrp8cre+ x CXCR4flox/flox LysM eGFP mice and their littermate controls into the 
normal C57BL/6 mice. One hour later, all mice were sacrificed and perfused 
with 4% PFA before harvesting the bones. For the staining CD41-PE, CD144 
and anti-GFP primary antibodies were used to label the MKs, vessels and 
transferred neutrophils in the bones, respectively. As shown in Figure 4.5.2.2, 
most transferring wildtype PMNs located in proximity to the MKs. However, 
homed CXCR4 knockout neutrophils were less frequently observed and 
distributed in random manner. This data strongly suggested that MKs may 
work as a SDF-1 reservoir like endothelial cells to attract homing neutrophils 
through the CXCR4-CXCL12 axis signaling pathway in the bone marrow.  
 Additionally, by live imaging we observed that some neutrophils migrated 
back to the bone marrow compartments along proplatelets (Fig.4.5.2.3) 
entering in close proximity to the proplatelet budding. Due to the short life span 
of neutrophils and maintenance the constant number of neutrophils in the 
peripheral blood, every day neutrophils follow the daily cycles of releasing from 
and migrating back to the BM when get aged. Hence, these homing 
neutrophils around the budding sites might be older “aged” neutrophils. Given 
the higher expression of CXCR4 on the aged neutrophils (Adrover JM, et al. 









Fig.4.5.2.1 Representative images of SDF-1(red) expression in MKs 









Fig.4.5.2.2 Megakaryocytes attract the PMNs in vivo  
(A) Representative whole mount images of PMNs distribution within the BM 1 
hour after transfer. CD144(blue), CD41(red), green anti-GFP (green). Scar bar, 
100μm. (B) localization of transferring PMNs (CXCR4-/- or CXCR4+/+ ) 
relative to MKs (N=4, error bars, mean±SEM, the numbers on the x axes in (B) 





















































Fig.4.5.2.3 Representative of PMNs extravasating along a protruding 
proplatelet towards the BM  
white arrows indicate the extravasated neutrophils, MKs display green 
fluorescence, neutrophils and vessel represent red and gray color, respectively. 
scale bar, 15μm 
  
4.5.3 CXCR4 guide PMNs to the budding site of proplatelets  
  
 Using an antibody labeling method (Stegner D. et al. 2017), we visualized 
the neutrophil and megakaryocyte interactions in the Mrp8cre x CXCR4flox/flox 
knockout mice. In comparison to the littermate control, Mrp8cre x CXCR4flox/flox 
knockout mice have higher numbers of neutrophils in the vascular 




the same phenotypes during thrombopoiesis as we found in the confetti mouse 
model under neutropenic condition (i.e. prolonged releasing time) 
(Fig.4.5.3.1A). The video analysis also (Fig.4.5.3.1B) indicated less PMN-MK 
interactions appeared around the budding sites of proplatelet forming 
megakaryocytes within the vascular niche. Additionally, the in vitro analysis of 
PAF numbers after co-culturing MKs with isolated CXCR4 knockout 
neutrophils also implies that CXCR4 on the neutrophils was indeed of critical 
importance for the platelets production in vitro. In summary, we concluded that 
Mrp8cre x CXCR4flox/flox mice had less platelet counts due to their defects of 












Fig.4.5.3.1 Quantification and assessment of proplatelet formation in 
Mrp8cre x CXCR4flox/flox mouse model.  
(A) representative images of proplatelet forming process in Mrp8cre- x 
CXCR4flox/flox and their littermate controls; dash line indicate the vessels, scale 
bar, 30μm (B) Analysis of proplatelet releasing numbers, time, growth speed, 
and interacted PMN numbers in circulation and bone marrow, etc. N=3, error 








Fig.4.5.3.2 Quantification of PAF number after co-culturing MKs with 
CXCR4 deficient PMNs  
N=3 per group, error bars, mean±SEM **P<0.01, ****P<0.0001, n.s 
non-significant, data representing 3 independent experiments, One-way 
ANOVA analysis was used for multiple group comparisons. 
 
4.6 Role of reactive oxygen species (ROS) on thrombopoiesis 
 
4.6.1 Inhibition of NADPH oxidase in neutrophils reduces the PAF 
generation in vitro 
 
 Aged neutrophils do not only show a higher expression of CXCR4, but also 
have different phenotypic changes in comparison to younger neutrophils 
(Adrover JM, et al. 2019). Previous studies have reported that reactive oxygen 









































production of MKs in the BM niches. Additionally, it is widely accepted that 
neutrophils are a big resource of ROS and recent study reports aged 
neutrophils exhibit a stronger capacity to produce ROS in comparison to young 
ones (Adrover JM, et al. 2019). Our previous data has mentioned that homing 
cells were critical importance of proplatelet forming and shedding. To 
investigate the role of neutrophil derived ROS during the thrombopoiesis, we 
were first to use, a broad inhibitor of the NADPH oxidase, apocynin, to block 
the neutrophil derived ROS and evaluated its effect on PAF production in vitro 
in our co-culture model. Flow cytometry analysis showed (Fig.4.6.1.1), that 
ROS inhibition in neutrophils blunts the additive effects of neutrophils on PAF. 
Additionally, p22phox mutated neutrophils (NADPH oxidase defect neutrophils) 
also showed a same trend (Fig.4.6.1.2) after co-culture with MKs. Taken 
together, these data suggest that ROS produced by neutrophils had a direct 





















































apocynin inhibited PMNs  
PMNs pre-incubated with cytoskeleton protein inhibitors before co-culturing 
with MKs, N=3 per group, error bars, mean±SEM *P<0.05, ****P<0.0001, data 
representing 3 independent experiments and One-way ANOVA analysis was 




Fig.4.6.1.2 Quantification of PAF number after co-culture MKs with 
p22phox mutated neutrophils  
N=3, error bars, mean±SEM, **P<0.01, ***P<0.001, n.s non-significant, data 
representing 3 independent experiments analyzed with One-way ANOVA 
followed by Tukey’s multiple comparison test. 
 
4.7 Circadian rhythm of platelets counts 
 
4.7.1 Platelets count oscillation regulated by circulating neutrophils 








































Even though we demonstrated that neutrophils augment platelet counts by 
interacting with MKs and releasing ROS molecules, the physiological 
relevance of this phenomenon is still elusive. Oscillation of neutrophil counts 
over the day seems to play a protective role in some cardiovascular diseases 
(i.e. myocardial infarction) (Adrover JM, et al. 2019). Previous studies reported 
that neutrophils numbers within circulation reach a peak at ZT5 (zeitgeber time 
5, 5 hours after light on) and a nadir at ZT13, respectively (María 
Casanova-Acebes, et al., 2013).  
Our findings indicated that MK-PMN interactions drive thrombopoiesis 
hence we addressed whether the number of circulating neutrophil affects 
platelet counts over the day. Hence, we evaluated platelet counts of a day at 
ZT5 and ZT13, respectively. Interestingly, platelet counts also presented a 
similar oscillation like neutrophils over the day (Fig.4.7.1.1). At ZT5, platelet 
and reticulated platelet counts were higher than those at ZT13. Among all 
observed leucocyte and lymphocyte populations only circulating neutrophils 
showed a circadian rhythm, suggesting that these circulating neutrophils may 







Fig.4.7.1.1 Circulating neutrophils regulate the platelet oscillation. 
(A) Blood counts of wildtype mice at ZT5 and ZT13, respectively. (B) 
Reticulated platelets were stained by thiazole orange and analyzed by flow 
cytometry at ZT5 and ZT13, respectively. (C) Blood and bone marrow, 
cellularity and number quantification of leukocyte subsets at ZT5 and ZT13, 
respectively N=4 male mice per group, error bars, mean±SEM *P<0.05, 
**P<0.01, ***P<0.001, ****P<0.0001,n.s nonsignificant, data representing two 
independent experiments analyzed with unpaired Student’s t-test. 
 
4.7.2 Oscillation of platelet counts depends on ICAM-1 and neutrophil 
expressed CXCR4 
 
To further investigate whether the same molecular mechanism of MK-PMN 















































































































































































ICAM-1 blocking mouse model and Mrp8cre x CXCR4flox/flox knockout mouse 
model. As above mentioned, ICAM-1 blocking or removal of CXCR4 on 
neutrophils would affect the platelet production due to the homing defect and 
avoidance of recruitment of homing neutrophils around budding sites. 
Interestingly, circadian modulation of platelet counts was blunted in both 
models (Fig.4.7.1.1) underscoring the close interdependency of platelet form 
PMN counts. 



















































































































































































































































































































































Fig.4.7.2.1 Platelet oscillation disappear in the LFA-1 blocked mice or 
Mrp8cre+ x CXCR4flox/flox mice 
(A)peripheral blood counts of LFA-1 blocked mice measured at ZT5 and ZT13, 
respectively. B. quantification of reticulated platelets fragment at ZT5 and ZT13, 
respectively. (C). Blood and bone marrow cellularity and numbers of 
leukocytes subpopulations in LFA-1 blocked mice (D) peripheral blood counts 
of Mrp8cre_CXCR4flox/flox knockout mice at ZT5 and ZT13, respectively. (E) 
Reticulated platelet counts at ZT5 and ZT13, respectively (F) Blood and bone 
marrow cellularity and leucocyte subsets numbers at ZT5 and ZT13, 
respectively (N=4 male mice per group, error bars, mean±SEM, n.s not 
significant, data representing two independent experiments analyzed with 






















Within the last decades several mechanisms were identified that regulate 
thrombopoiesis under steady state or inflammatory conditions including 
sphingosine 1-phosphate, IL-1alpha, and CCL5. However, the role of the 
cellular microenvironment on proplatelet formation and release is still poorly 
understood. In this study we provide evidence that homing aged neutrophils 
promote proplatelet shedding through generation of ROS molecules. 
Our findings demonstrate that a long time depletion of neutrophils in a 
conditional knockout mouse model (Rosa26iDTR x Mrp8Cre mouse) can 
attenuate platelet production and subsequently reduce platelet counts by 30% 
compared to controls. However, even though neutrophils are completely 
eliminated through diphtheria toxin receptor-mediated conditional ablation, 
platelet counts only showed a one-third decrease with no additional effect after 
5 days of treatment. A previous study (Laurent L. Reber et al., 2017) reported 
that a single treatment of Rosa26iDTR x Mrp8Cre mice with diphtheria toxin also 
leads to a slight but not significant decrease of thrombocytes possibly due to 
sex and age differences between the mice. However, thrombopoiesis was not 
completely diminished in the absence of neutrophils. Likewise, Ly6G/C 
antibody mediated neutrophil depletion in C57BL/6 wildtype mice also yielded 
reduced platelet counts (around 25% and 33% reduction at day 3 and day 5, 
respectively) over time. Importantly, both neutropenic mouse models did not 
show an alteration in the number or maturation (i.e. ploidy) of CD41+CD42d+ 
megakaryocytes, indicating that neutrophil depletion did not affect 
megakaryopoiesis but rather influences the level of thrombopoiesis. This is in 
line with our finding that the fraction of reticulated platelets is reduced under 
neutropenia, whereas platelet lifespan and clearance are not altered. In 




production, not the clearance.  
A second key finding of our study is that neutrophils within the vascular 
compartment play the predominant role during the thrombopoiesis. The bone 
marrow interstitium and vasculature are the two main neutrophil pools. The 
bone marrow interstitium serves as a site of neutrophils production and 
clearance to maintain the cellular homeostasis and immunity balance by 
chemokine signaling communications (María Casanova-Acebes, et al., 2013). 
The circulating pool within the vasculature that predominantly consists of 
mature and aged neutrophils represents innate immunity to maintain body 
integrity and to tackle invading pathogens (Charlotte Summers, et al., 2010.) 
Indeed, the vascular pool mediates the effects on thrombopoiesis, given that 
we did not observe an additional effect in our iDTR neutropenic model that 
depletes both PMN pools in contrast to the antibody depletion model that only 
reduces the intravascular pool. 
Using multiphoton intravital microscopy, we were first to visualize physical 
interactions between neutrophils and megakaryocytes. Importantly these 
interactions occur within the BM interstitium as well as the vascular 
compartment. However, using sphericity index to categorize MKs, we 
observed a different interaction dynamic in highly differentiated MKs (low 
sphericity index) with a high capacity to form proplatelets: they establish more 
and longer lasting interactions with PMNs compared to less proliferative MKs 
(high sphericity index). To further characterize MK-PMN interaction during 
platelet production we visualized proplatelet formation within the BM in the 
presence and absence of neutrophils in two fluorescent reporter gene mouse 
models. Our data from the antibody depletion experiments reveals that 
MK-PMN interactions within the bone marrow niche do not change before and 
after depletion. Worthy of note, no interaction can be found within the 




proplatelet formation speeds and prolonged shedding times, but no changes 
concerning the proplatelet lengths, underscoring the importance of PMNs 
within the bloodstream.  
By quantifying distances from interacting PMNs to proplatelet budding 
sites our data suggest that PMN residing in close proximity to the budding site 
(<20μm) play the dominant role on proplatelet formation and shedding. 
Given the intrinsic limitations to study MK-PMN interactions and its 
molecular basis in vivo we established an in vitro co-culture model. Hence, we 
were able to investigate whether a direct physical interaction or paracrine 
signaling events drive proplatelet formation and shedding. A borden chamber 
based in vitro co-culture assay indicates physical interaction is indispensable 
for this neutrophil mediated platelet biogenesis. Furthermore, cytokines 
released by activated PMNs likewise showed the paracrine signaling events 
are not of critical importance to augment the proplatelet forming and shedding 
in vitro. 
MK-PMN interactions are preceded PMN endothelial cell interactions, we 
found that ICAM-1 blocking yields reduced platelet counts as seen before in 
the absence of intravascular PMN. Additionally, Efalizumab, a monoclonal 
ICAM-1 blocking antibody, no longer clinically available due to sporadic but 
deadly severe infections, induced thrombocytopenia as a common side effect 
in patients (Hostetler SG, et al. 2007). Taken together, our data show that the 
intravascular, vessel wall adherent pool of PMNs that localize in proximity to 
the proplatelet budding site drive thrombopoiesis. 
Next, we aimed to identify the mechanism that triggers PMN recruitment to 
proplatelet budding sites. Previous studies have demonstrated that platelets 
resemble a reservoir of SDF-1alpha, and also MKs are capable of secreting 
CXCL12 (Steffen Massberg, et al. 2006). Further it was shown that the 




Mature and activated neutrophils accompany with increased SDF-1 induced 
calcium influx and higher CXCR4 expression. Neutralization by low dose 
CXCR4 antibody reduces the neutrophils sequestration and retention in the 
BM (Suratt BT, et al. 2004). Hence, megakaryocyte derived CXCL12 mediates 
the neutrophil recruitment to megakaryocytes, additionally, especially aged 
neutrophils that home back to the BM highly express CXCR4 
(Casanova-Acebes, et al. 2013). Hence the removal of CXCR4 on neutrophils 
in mice leads to leukocytosis due to a defect of the neutrophils homing capacity. 
Interestingly, this mouse model shows reduced platelet counts, as seen before 
in the absence of PMN, underscoring the importance of the neutrophils 
CXCR4 expression on platelet biogenesis. But what are the links between 
them? In vivo visualization revealed that the removal of CXCR4 on the 
neutrophils leads to decreased neutrophil interactions within the vascular niche. 
This is in line with our hypothesis that neutrophil recruitment to proplatelet 
forming MKs drives thrombopoiesis. Previous studies have demonstrated that 
CXCL12 can be released by endothelial cells and regulate the lineage biased 
HSCs distribution in vivo (Sandra Pinho, et al. 2018). Hence, we sought to 
determine whether MKs or endothelial cells dominated the attraction of 
attached neutrophils to MKs in the circulation. Adoptively transferred neutrophil 
experiments revealed that the removal of CXCR4 on neutrophils leads to a 
random distribution of neutrophils within the bone marrow niche, whereas 
wildtype neutrophils showed a specific MK-orientated distribution. This finding 
suggests that the homing of aged neutrophils might be extrinsically driven by 
endothelial cells and MKs together. In addition to endothelial cells in bones, 
MKs might be another source of CXCL12 that mediates cell migration and 
distribution in the bone marrow niche.  
Neutrophils originate from myeloid biased HSCs within the bone marrow 




against the pathogens. Due to their short lifespan (approximately 5~6 hours) 
neutrophils are continuously produced in the bone marrow and cleared in 
specialized organs (i.e. bone marrow, liver) by phagocytes to maintain a 
constant number in the bloodstream. This production-clearance dynamic 
entails a good balance between the release of young neutrophils and the 
clearance of aged ones. The young neutrophils transformation into aged ones 
implies not merely the phenotypic changes, but moreover the functional 
diversification. In contrast to young neutrophils, aged neutrophils are smaller 
and less granular. Murine neutrophils present increased CXCR4 but reduced 
CD62L (also known L-selectin) expression while in the circulation. 
Transcriptomic analyses show that aged neutrophils exhibit many 
pro-inflammatory genes (i.e. TNF-α) as neutrophils are activated by 
inflammatory stimuli throughout their time in the circulation. Further studies 
demonstrated that aged neutrophils favor a pro-inflammatory phenotype (i.e. 
NETosis formation) that predisposes to vascular inflammation (i.e. myocardial 
infarction) (Adrover JM, et al. 2019). Under inflammatory conditions activation 
of integrins or G-protein-coupled receptors on neutrophils triggers the 
production of reactive oxidative species (ROS) to subsequently activate 
proteinases (i.e. Myeloperoxidase) and to form extracellular NETs (Nguyen GT, 
et al. 2017). In this context, aged neutrophils were found to generate increased 
amounts of ROS than “fresh” neutrophils (Adrover JM, et al. 2019). ROS is 
known to regulate the HSCs proliferation, differentiation, as well as MKs 
maturation (Chen S, Su Y, Wang J. 2013). In addition, a lipid mediator, 
15-Deoxy-D12,14-PGJ2, was shown to directly influence platelet release 
through promotion of the redox state in the MKs and change of the cellular 
cytoskeleton. This finding indicates that the platelet biogenesis process can be 
directly influenced by ROS molecules (O’Brien JJ, et al. 2008). In our setting 




within neutrophils that would recede the effect of platelet production by 
neutrophils in vitro, Likewise, a co-culture of MKs with neutrophils isolated from 
the NADPH oxidase mutated mice (p22phox mutation mice) also proved that 
proplatelets formation was neutrophil-derived-ROS dependent. Additionally, 
p22phox mutation mice similarly displayed a thrombocytopenic phenotype and a 
decrease in the generation of reticulated platelets (data not shown). Due to a 
global p22phox mutation in this mouse line, the role of other ROS producing cell 
types, in particular endothelial cell, are difficult to exclude. Nevertheless, we 
still could conclude that ROS is of critical importance for the platelet biogenesis 
in vivo.  
  Aged neutrophils exhibit an intrinsic circadian oscillation to meet the 
various diurnal challenges. In the model of acute myocardial infarction the 
extent of the myocardial damage displays a diurnal variation, and infarct size 
exhibits a strong negative correlation with the number of aged neutrophils in 
the circulation, indicating that aged neutrophils play a protective role in tissues 
after ischemia/ reperfusion (Adrover JM, et al. 2019). In analogy we and others 
found that platelet counts and their functions vary over the day. In addition, 
husbandry conditions impact on this oscillation to some extent (Hartley PS. 
2013). Nevertheless, the underlying mechanisms that regulate this variation in 
platelet counts remain obscure. However, our data uncovered that neutrophil 
and platelet counts oscillate in the same phase, an effect that can be abolished 
by interfering with PMN homing to the BM after ICAM-1 block or in the absence 
of CXCR4 on neutrophils. Interestingly, the fluctuating platelet counts 
accounted for about 30% of total platelets in the mice analogous to the platelet 
number at ZT5 and ZT13, respectively.  
 Taken together, our study identified aged PMN as drivers of 
thrombopoiesis by releasing ROS. This newly identified mechanism that 




immune system and primary hemostasis, two closely linked mechanisms. The 
suggested mechanism resembles a new fast and direct way to govern different 
platelet demands under conditions of increased platelet demands as found in 
various physiological and pathological conditions (i.e. trauma) (N. Valade, et al. 
2005).   
Hence our findings do not merely give insight into a novel concept of 
platelet biogenesis involving the interaction between MKs with other immune 
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